Literature DB >> 2813787

Hepatic arterial chemotherapy: role of angiography.

K J Cho1, J C Andrews, D M Williams, F Doenz, G E Guy.   

Abstract

Hepatic arterial infusion chemotherapy increases the hepatic concentration of chemotherapeutic agents without increasing systemic toxicity. Both percutaneous (most commonly left transbrachial) and surgical approaches are currently used for infusion catheter placement. Surgical catheter and pump placement has proved to be a reliable means of delivering drugs to the liver and has been commonly used for hepatic arterial chemotherapy for metastatic colorectal carcinoma. Meticulous angiographic evaluation of the hepatic vascular anatomy, its variations, and hemodynamics is necessary for correct catheter placement to achieve total liver perfusion without significant extrahepatic perfusion. Satisfactory hepatic perfusion should be documented before drug infusion. Hepatic arterial radionuclide flow imaging with technetium-99m-labeled macroaggregated serum albumin remains the most reliable means of assessing hepatic perfusion following catheter placement. Transcatheter techniques have been used to facilitate catheter placement, to prevent gastrointestinal drug toxicity, and to correct unsatisfactory perfusion following surgical catheter placement.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813787     DOI: 10.1148/radiology.173.3.2813787

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  A randomized trial of intrahepatic arterial infusion of 4'-epidoxorubicin with Lipiodol versus 4'-epidoxorubicin alone in the treatment of hepatocellular carcinoma.

Authors:  M Yoshikawa; H Saisho; M Ebara; T Iijima; S Iwama; F Endo; M Kimura; Y Shimamura; Y Suzuki; T Nakano
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

2.  Intra-arterial infusion of N-isopropyl-p[123I]iodoamphetamine for assessing effective blood supply to pulmonary and hepatic neoplasms.

Authors:  C Miyazaki
Journal:  Ann Nucl Med       Date:  1994-05       Impact factor: 2.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.